🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06857630
Recruiting Observational

Preoperative Hemoglobin and Acute Kidney Injury in Emergency Surgery

NCT06857630 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-01-01
Last updated
2026-03-17

Condition(s) studied

Emergency SurgeryAcute Kidney InjuryHemoglobin

Investigational drug(s) / intervention(s)

Observational

Observational: Postoperative acute kidney injury and hemoglobin level relationship observation

Study summary

Optimization of hemoglobin levels for organ perfusion is essential, especially in critically ill patients. Although anemia is associated with severe organ failure, especially in coronary artery disease, the effects of blood transfusion or various interventions to increase hemoglobin levels on outcomes continue to be debated. The effects of hemoglobin levels in emergency surgery patients on the development of postoperative AKI have been investigated in a small number of studies in the literature, and clear results have not yet been reported. This study was designed to evaluate the effect of hemoglobin levels on the development of AKI after adjustment for known predictive factors.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing emergency non-cardiac surgery Exclusion Criteria: * Known renal failure * Need for reoperation within 48 hours postoperatively * Exit status within 48 hours postoperatively * Known hematological disease * Known kidney transplantation * Urgent surgery planned due to urinary system related diseases * Patients who did not accept to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Özgür Kömürcü Samsun Turkey (Türkiye) Recruiting

More Samsun University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06857630 on ClinicalTrials.gov ↗ ← All trials in Turkey